CIK 0001787306 · Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812974255
- Phone
- 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,318,251
- in 11 filings, $2.1M under 10b5-1 plans
Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,019 | 9,163 | ||
| 2026-08-17 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,255 | 20,287 | ||
| 2026-08-12 | Burnett Patrick See Remarks | Option exercise | +6,700 | $3.64 | $24K | 125,989 |
| 2026-08-12 | Burnett Patrick See Remarks | Sale | −6,700 | $26.08 | $175K | 119,289 |
| 2026-08-12 | Burnett Patrick See Remarks | Option exercise · Stock Option (right to buy) | −6,700 | 128,750 | ||
| 2026-08-11 | Burnett Patrick See Remarks | Option exercise | +8,300 | $3.64 | $30K | 127,589 |
| 2026-08-11 | Burnett Patrick See Remarks | Sale | −8,300 | $26.52 | $220K | 119,289 |
| 2026-08-11 | Burnett Patrick See Remarks | Option exercise · Stock Option (right to buy) | −8,300 | 135,450 | ||
| 2026-08-03 | Burnett Patrick See Remarks | Sale 10b5-1 | −955 | $26.12 | $25K | 119,289 |
| 2026-08-03 | Matsuda Masaru See Remarks | Sale 10b5-1 | −1,230 | $26.12 | $32K | 126,171 |
| 2026-08-03 | Watanabe Todd See Remarks | Sale 10b5-1 | −4,375 | $26.12 | $114K | 717,203 |
| 2026-07-15 | Peetz Christopher Director | Grant or award | +4,315 | 4,315 | ||
| 2026-07-15 | Peetz Christopher Director | Grant or award · Stock Option (right to buy) | +21,486 | 21,486 | ||
| 2026-07-15 | Peetz Christopher Director | Grant or award · Stock Option (right to buy) | +13,010 | 13,010 | ||
| 2026-07-15 | Welgus Howard G. Director | Option exercise 10b5-1 | +822 | $6.52 | $5K | 38,565 |
| 2026-07-15 | Welgus Howard G. Director | Option exercise 10b5-1 | +1,019 | $7.51 | $8K | 39,584 |
| 2026-07-15 | Welgus Howard G. Director | Option exercise 10b5-1 | +2,255 | $8.63 | $19K | 41,839 |
| 2026-07-15 | Welgus Howard G. Director | Sale 10b5-1 | −4,730 | $26.91 | $127K | 37,109 |
| 2026-07-15 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −822 | 8,218 | ||
| 2026-07-15 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,019 | 10,182 |
Page 3 of 13 · 241 trades